Based on these findings, we propose a predictor model that categorizes tumor-specific CD8+ T cells into Tpex1 (stem-like precursors associated with favorable ICI response), Tpex2, and Tex (cell states linked to ICI resistance). The gene discussed is CD8A; the disease is neoplasm.